共3页/46条首页上一页123下一页尾页
回复:46 阅读:9980
B2160浸润性导管癌伴大汗腺特征,morphology like histiocytoid or granular cell tumor (cqz-24) 7-16-2009

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
楼主 发表于 2009-07-16 22:51|举报|关注(4)
浏览排序[ 顺序 逆序 楼主 支持 精彩 ]  快捷回复

This is a case this week. I feel interesting. Share with your guys.

about 50 y/f breast lesion 2 cm in imaging.

abin译:

这是本周的一个病例,我觉得有意义,与大家分享。

大概50岁女性,影像学示2cm病变。

 

  • 浸润性导管癌伴大汗腺特征,morphology like histiocytoid or granular cell tumor (cqz-24) 7-16-2009图1
    图1
  • 浸润性导管癌伴大汗腺特征,morphology like histiocytoid or granular cell tumor (cqz-24) 7-16-2009图2
    图2
  • 浸润性导管癌伴大汗腺特征,morphology like histiocytoid or granular cell tumor (cqz-24) 7-16-2009图3
    图3
  • 浸润性导管癌伴大汗腺特征,morphology like histiocytoid or granular cell tumor (cqz-24) 7-16-2009图4
    图4
标签:浸润性导管癌伴大汗腺特征
本帖最后由 于 2009-08-22 19:05:00 编辑
0
添加参考诊断
×参考诊断
  

x7562181 离线

帖子:145
粉蓝豆:16
经验:153
注册时间:2007-09-14
加关注  |  发消息
1 楼    发表于2011-03-08 20:12:00举报|引用
返回顶部 | 快捷回复
 
     学习了
0
回复

xjhb-yq 离线

帖子:395
粉蓝豆:6296
经验:1361
注册时间:2008-04-25
加关注  |  发消息
2 楼    发表于2010-05-20 18:49:00举报|引用
返回顶部 | 快捷回复

确实是好病例,受益匪浅,学习了。

0
回复
signature

xclbljys 离线

帖子:5253
粉蓝豆:224
经验:7005
注册时间:2008-11-21
加关注  |  发消息
3 楼    发表于2010-05-19 19:13:00举报|引用
返回顶部 | 快捷回复
 
    

大开眼界!

0
回复
signature
许春雷

carson 离线

帖子:29
粉蓝豆:1
经验:29
注册时间:2009-11-12
加关注  |  发消息
4 楼    发表于2009-11-16 22:15:00举报|引用
返回顶部 | 快捷回复

收藏

0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
5 楼    发表于2009-11-15 22:32:00举报|引用
返回顶部 | 快捷回复
以下是引用ZQH19811029在2009-11-15 18:46:00的发言:

考虑:浸润性小叶癌。

Thanks if you are a pathologist
0
回复

ZQH19811029 离线

帖子:458
粉蓝豆:1
经验:458
注册时间:2009-11-15
加关注  |  发消息
6 楼    发表于2009-11-15 18:46:00举报|引用
返回顶部 | 快捷回复

考虑:浸润性小叶癌。

0
回复

czyxyysm 离线

帖子:359
粉蓝豆:335
经验:1315
注册时间:2007-12-31
加关注  |  发消息
7 楼    发表于2009-10-27 08:36:00举报|引用
返回顶部 | 快捷回复

学习啦

0
回复
signature
杨苏敏

zouluosi0407 离线

帖子:75
粉蓝豆:430
经验:559
注册时间:2008-06-10
加关注  |  发消息
8 楼    发表于2009-10-24 13:50:00举报|引用
返回顶部 | 快捷回复

大开眼界!

0
回复

yongping 离线

帖子:352
粉蓝豆:1
经验:363
注册时间:2009-09-17
加关注  |  发消息
9 楼    发表于2009-10-22 09:35:00举报|引用
返回顶部 | 快捷回复
 学习了
0
回复
signature
Look beyond what you see.

贝贝 离线

帖子:851
粉蓝豆:15
经验:1510
注册时间:2007-11-23
加关注  |  发消息
10 楼    发表于2009-10-19 22:26:00举报|引用
返回顶部 | 快捷回复
 i学习了
0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
11 楼    发表于2009-08-15 13:08:00举报|引用
返回顶部 | 快捷回复
以下是引用gpren2002在2009-8-15 7:23:00的发言:

 浸润性小叶癌或 化生性癌,需免疫组化帮助

Thank for your kind of suggestion.
0
回复

abin 离线

帖子:7416
粉蓝豆:6014
经验:11787
注册时间:2006-10-08
加关注  |  发消息
12 楼    发表于2009-08-15 12:52:00举报|引用
返回顶部 | 快捷回复
 ER-,PR-,HER2+仍然符合浸润性大汗腺癌,尽管组织学级别不高,预后较差。
0
回复
signature

华夏病理/粉蓝医疗

为基层医院病理科提供全面解决方案,

努力让人人享有便捷准确可靠的病理诊断服务。


abin 离线

帖子:7416
粉蓝豆:6014
经验:11787
注册时间:2006-10-08
加关注  |  发消息
13 楼    发表于2009-08-15 12:50:00举报|引用
返回顶部 | 快捷回复
 Breast Cancer. 2002;9(1):43-9.

Histological and immunohistochemical analysis of apocrine breast carcinoma.

Matsuo K, Fukutomi T, Hasegawa T, Akashi-Tanaka S, Nanasawa T, Tsuda H.

Department of Surgical Oncology, National Cancer Center Hospital, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan.

BACKGROUND: There are few data regarding the biological characteristics of apocrine breast carcinoma in the literature due to its rarity and controversy over its definition. We analyzed the histopathological characteristics and tumor biology of apocrine breast carcinomas with regard to histological grade, p53, HER2, bcl-2, MIB-1 and hormone receptor status. PATIENTS AND METHODS: A consecutive series of 24 female apocrine breast carcinoma patients were the primary source of these retrospective data. Background factors including histological grade, nodal status and lymphatic invasion by tumor cells were analyzed. Immunohistochemical staining for p53, HER2, MIB-1, bcl-2, estrogen receptor (ER) and progesterone receptor (PR) was carried out on formalin-fixed, paraffin embedded specimens. RESULTS: Older age and postmenopausal status were observed more frequently in patients with apocrine breast carcinoma than those with invasive ductal carcinoma. Apocrine breast carcinoma also showed relatively lower histological grade than invasive ductal carcinoma. Nuclear accumulation of p53, HER2 overexpression, bcl-2 and MIB-1 index were observed in 29% (7/24), 33%(8/24), 25%(6/24) and 29% (7/24) of cases, respectively. Positivity for ER and PR was present in 17% (4/24) and 17% (4/24) of cases, respectively. CONCLUSIONS: Apocrine breast carcinoma tended to show low MIB-1 index, low bcl-2 expression and low positive rate of hormone receptors. There was no correlation between the three types of apocrine carcinoma and the positivity rate of p53, HER2, bcl-2, MIB-1 and hormone receptor status.

PMID: 12196721 [PubMed - indexed for MEDLINE]
该研究组中,免疫组化HER2阳性率33%(8/24)。
0
回复
signature

华夏病理/粉蓝医疗

为基层医院病理科提供全面解决方案,

努力让人人享有便捷准确可靠的病理诊断服务。


abin 离线

帖子:7416
粉蓝豆:6014
经验:11787
注册时间:2006-10-08
加关注  |  发消息
14 楼    发表于2009-08-15 12:47:00举报|引用
返回顶部 | 快捷回复
 Histopathology. 2004 Apr;44(4):332-8.
Click here to read
Preferential HER-2/neu overexpression and/or amplification in aggressive histological subtypes of invasive breast cancer.

Varga Z, Zhao J, Ohlschlegel C, Odermatt B, Heitz PU.

Department of Pathology, University Hospital Zurich, Zurich. zsuzsanna.varga@usz.ch

AIMS: To investigate whether alterations of the HER2 gene occur more frequently in histologically unfavourable subtypes of invasive breast cancer. METHODS: The study was composed of nine invasive apocrine, six lipid-rich, 12 glycogen-rich, 11 micropapillary and 33 pleomorphic lobular breast carcinomas. Lymph node involvement was represented in all subgroups. HER2 status was confirmed in all cases by using immunohistochemistry (CB11, Herceptest) and fluorescent in-situ hybridization (FISH) analysis (Vysis). RESULTS: Micropapillary and apocrine carcinomas showed the highest rate of protein overexpression (72% and 66%) and gene amplification (45% and 44%). Protein overexpression was common in poorly differentiated pleomorphic lobular carcinomas (56%); however, this subgroup failed to show an increased number of gene copies by FISH (31%). The incidence of HER2 overexpression (33% and 50%, respectively) and gene amplification (25% and 33%, respectively) among glycogen-rich and lipid-rich carcinomas was not higher than that observed in breast cancer generally. CONCLUSION: Our data suggest that preferential involvement of the HER2 gene in micropapillary and apocrine breast carcinomas may contribute to their aggressive behaviour.

PMID: 15049898 [PubMed - indexed for MEDLINE]
该研究组中,微乳头型和大汗腺型癌的HER2蛋白表达率(72% and 66%) 和基因扩增率(45% and 44%)最高,可能是其预后差的原因。
0
回复
signature

华夏病理/粉蓝医疗

为基层医院病理科提供全面解决方案,

努力让人人享有便捷准确可靠的病理诊断服务。


gpren2002 离线

帖子:200
粉蓝豆:101
经验:235
注册时间:2007-06-30
加关注  |  发消息
15 楼    发表于2009-08-15 07:23:00举报|引用
返回顶部 | 快捷回复
 浸润性小叶癌或 化生性癌,需免疫组化帮助
0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
16 楼    发表于2009-08-15 07:07:00举报|引用
返回顶部 | 快捷回复
本帖最后由 于 2009-08-15 20:06:00 编辑

 Thank Abin for your contribution for this case. We signed out this biopsy case as invasive ductal carcinoma with apocrin feature. Apocrine ca is a subtype of ductal ca. Basically invasive apocrine ca and invasive usual ductal ca have similar prognosis.

As Abin mentioned classic IHC of apocrin ca: GCDFP-15+, BCL 2-, ER-, PR-.

Interesting part for this case is the morphologic features in breast core biopsy. The breast core bx specimen demonstrated the cytomorphologic features more like granular cell tumor, histiocytic lobular ca. The metastatic tumor in axillary lymph node has some features of apocrine tumor.

Thank all of you who read and attended the discussion for this case.

cz

 

abin译:
谢谢abin为本例的贡献。我们活检签发的是浸润性导管癌伴大汗腺特征。大汗腺癌是导管癌的一个亚型。浸润性大汗腺癌和浸润性导管癌有相似的预后。
正如abin提到的,大汗腺癌典型的免疫组化:GCDFP-15+, BCL 2-, ER-, PR-。
本例有趣之处在于,粗针穿刺活检时的形态学特征:细胞形态学特点更像颗粒细胞瘤和组织细胞样小叶癌。腋窝淋巴结转移肿瘤有大汗腺肿瘤的某些特征。
谢谢所有阅读并参与讨论的人。
cz

0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
17 楼    发表于2009-08-14 12:04:00举报|引用
返回顶部 | 快捷回复
本帖最后由 于 2009-08-14 12:08:00 编辑

 F 1: ER

F2: Her2

PR negative


名称:图1
描述:图1

名称:图2
描述:图2
0
回复

天山望月 离线

帖子:4902
粉蓝豆:83
经验:5092
注册时间:2007-02-03
加关注  |  发消息
18 楼    发表于2009-08-13 22:28:00举报|引用
返回顶部 | 快捷回复

 哈哈,abin谈的是孙子兵法哦,分析的太好了。

感谢Dr.zhao提供经典完整的病例!

0
回复
signature
广州金域病理

abin 离线

帖子:7416
粉蓝豆:6014
经验:11787
注册时间:2006-10-08
加关注  |  发消息
19 楼    发表于2009-08-13 22:08:00举报|引用
返回顶部 | 快捷回复
本帖最后由 于 2009-08-15 12:57:00 编辑

E-Ca阳性而p120阴性,提示为浸润性导管癌,可能是特殊类型,HE形态似浸润性大汗腺癌。

支持浸润性大汗腺癌的HE形态:除以上HE形态特征外,有大汗腺型DCIS。

支持浸润性大汗腺癌的其它免疫组化:GCDFP15+,AR+,Bcl2-,S-100-,ER-,PR-。特染D-PAS+。

(我没见过真正病例,以上是书上学来的,纯属纸上谈兵)

0
回复
signature

华夏病理/粉蓝医疗

为基层医院病理科提供全面解决方案,

努力让人人享有便捷准确可靠的病理诊断服务。


flyaqmt 离线

帖子:134
粉蓝豆:23
经验:211
注册时间:2007-09-18
加关注  |  发消息
20 楼    发表于2009-08-11 19:10:00举报|引用
返回顶部 | 快捷回复
 浸润性导管癌,我们上周读片有一例是小叶癌 ,我一直以为是小叶癌啦。
0
回复
signature
虽然偶尔有梦想照进现实,但真正实现梦想却是蜀道难,难于上青天!
回复:46 阅读:9980
共3页/46条首页上一页123下一页尾页
【免责声明】讨论内容仅作学术交流之用,不作为诊疗依据,由此而引起的法律问题作者及本站不承担任何责任。
快速回复
进入高级回复
您最多可输入10000个汉字,按 "Ctrl" + "Enter" 直接发送
搜索回复/乘电梯 ×
按内容
按会员
乘电梯
合作伙伴
友情链接